Jie Wang

Overview:

I completed my hematology/oncology fellowship training and Masters of Science in Translational Research at the University of Pennsylvania.  I am dedicated to the treatment of lymphoma and have developed a specific interest in the T cell lymphomas.  I am inspired by the opportunity for the development of new treatments, and aspire to be a clinical investigator in the Division of Hematologic Malignancies and Cellular Therapy.  My recent research has focused on the development of immune therapies for the treatment of T cell malignancies.  I believe that novel approaches are needed in this group of diseases. 

Positions:

Medical Instructor in the Department of Medicine

Medicine, Hematological Malignancies
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Education:

M.D. 2010

The University of Chicago, Pritzker School of Medicine

Internal Medicine Internship and Residency

University of Michigan, Ann Arbor

Hematology/Oncology Fellowship

University of Pennsylvania, School of Medicine

Lymphoma Translational Research Fellowship

University of Pennsylvania, School of Medicine

Grants:

A Phase I, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A bispecific DART Protein binding PD-1 and LAG-3 in Patients with Unresectable or Metastatic Neoplasms

Administered By
Duke Cancer Institute
Awarded By
MacroGenics, Inc.
Role
Principal Investigator
Start Date
End Date

Publications:

Complete Response of a Young Woman With MYD88WT Bing-Neel Syndrome on Ibrutinib Monotherapy Following a Single Cycle of B Hyper-CVAD/IT MTX.

Authors
Pabon, CM; Neff, JL; Forns, TE; Wang, J
MLA Citation
Pabon, Cindy M., et al. “Complete Response of a Young Woman With MYD88WT Bing-Neel Syndrome on Ibrutinib Monotherapy Following a Single Cycle of B Hyper-CVAD/IT MTX.Clin Lymphoma Myeloma Leuk, June 2020. Pubmed, doi:10.1016/j.clml.2020.06.004.
URI
https://scholars.duke.edu/individual/pub1451623
PMID
32660904
Source
pubmed
Published In
Clin Lymphoma Myeloma Leuk
Published Date
DOI
10.1016/j.clml.2020.06.004